Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Recent health policy documents have endorsed an integrated model of collaboration between pharmacists and physicians in primary care. The integration of pharmacists into primary care has been identified as a priority for primary health care reform in Canada. However, the best way to do this has not been demonstrated or evaluated. This demonstration project shows the various ways in which pharmacists can be trained and integrated into different family practice settings, the processes and costs associated with doing this, and the outcomes observed. The main hypothesis is that pharmacist integration into family practice will optimize medication use, clinical care and clinical outcomes. This information provides policy makers with necessary information about collaboration between pharmacists and family physicians for their overall goal of reforming the delivery of primary health care to the population.
The overall goal of IMPACT was to improve patient outcomes by optimizing drug therapy through a community practice model that integrates pharmacists into family practices.
This multi-site demonstration project involved 7 pharmacists, approximately 70 physicians and approximately 150,000 patients. Within each practice site, a pharmacist with special clinical training worked 2.5 days per week for 2 years and coordinated a multifaceted intervention aimed at optimizing drug therapy to improve patient outcomes (blood pressure, cholesterol, diabetes, pain control, constipation, etc.) The integrated pharmacist conducted patient assessments for medication problems, optimized office system medication management (e.g. develop process for handling of medication samples), and provided education (academic detailing ) focussed on key therapeutic areas. Pharmacists were provided with ongoing support from a training and mentorship program and the services of the Ontario Pharmacists' Association Drug Information Centre.
The family physicians and other members of the practice worked closely with the pharmacist in implementing these strategic interventions. Family physicians from a range of practice models (Ontario Family Health Networks, Primary Care Networks, and other types of family physician group practices) participated in this project.
Quantitative and qualitative methods were used to evaluate the process of integration, pharmacist service uptake, drug-related patient outcomes, and the costs associated with program implementation for sustainability. The integration of the physicians and pharmacists at the practice sites were evaluated with the aim of generating a practical and transferable practice model. The main hypothesis was that pharmacist integration into family practice will optimize medication use, clinical care and clinical outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| integration of pharmacist into primary care | Behavioral | |||
| optimizing therapeutic treatments | Drug | |||
| optimizing processes of care | Behavioral |
| Measure | Description | Time Frame |
|---|---|---|
| Number and types of patients referred and assessed | ||
| Characterization and quantification of pharmacist activities | ||
| Numbers and types of drug-related problems identified and resolved | ||
| Medication changes made | ||
| Number of recommendations implemented | ||
| Process indicators (measurement of blood pressure, Cholesterol, hemoglobin A1C) | ||
| Surrogate clinical outcomes (values of blood pressure, Cholesterol, hemoglobin A1C) | ||
| Symptom improvement (constipation, pain) |
| Measure | Description | Time Frame |
|---|---|---|
| Health resource utilization | ||
| Satisfaction with service | ||
| Uptake of pharmacist recommendations |
Not provided
Inclusion Criteria:
65 + years and any two of the following:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lisa Dolovich, PharmD, MSc | McMaster University | Principal Investigator |
| Kevin Pottie, MD | University of Ottawa, Ottawa ON | Principal Investigator |
| Janusz Kaczorowski, PhD | McMaster University | Principal Investigator |
| Barbara Farrell, PharmD | Elisabeth Bruyere Research Institute, Ottawa, ON | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| McMaster University | Hamilton | Ontario | L8N 1G6 | Canada | ||
| University of Ottawa |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Extent of knowledge translation |
| Extent of collaboration |
| Satisfaction with integrated pharmacist program |
| Set up costs |
| Pharmacist and physician time costs |
| Travel cost |
| Space requirements |
| Medication costs |
| Health services utilization |
| Ottawa |
| Ontario |
| K1N 5C8 |
| Canada |
| University of Toronto | Toronto | Ontario | M5S 2S2 | Canada |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D006973 | Hypertension |
| D006949 | Hyperlipidemias |
| D003248 | Constipation |
| D010146 | Pain |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009461 | Neurologic Manifestations |
Not provided
Not provided